Our study indicated that taking SePN instead of PN might boost antioxidant capacity, glucolipid metabolism enzyme activities, PPARα and PCSK9 pathway regulation, and gut microbiota improvement linked to glucolipid metabolism, lowering the risk of hyperglycemia, hyperlipidemia, and inflammatory reactions induced by the HFD. The gene discussed is PPARA; the disease is Hyperglycemia.